Dr. Shailesh R. Basani, MD
Nephrology (Kidney) (Nephrology Physician)
- Medicare participating
At a glance
- Years since graduation
- 26
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 322
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Nephrology Physician primary
GA license 84952 · IN license 01071094A -
Internal Medicine Physician
GA license 84952 · IN license 01071094A
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Northside Hospital Atlanta, GA
- Northside Hospital Forsyth Cumming, GA
Medical groups
- Peachtree Nephrology PC (6 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 322
- Services billed
- 1,520
- Patients’ average age
- 78
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 581 | 165 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 312 | 136 |
| Established patient office or other outpatient visit, 30-39 minutes | 142 | 66 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 129 | 119 |
| Critical care, first 30-74 minutes | 124 | 38 |
| Established patient office or other outpatient visit, 40-54 minutes | 48 | 22 |
| New patient office or other outpatient visit, 60-74 minutes | 26 | 26 |
| Established patient office or other outpatient visit, 20-29 minutes | 19 | 15 |
| Urinalysis, manual test | 14 | 14 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Amlodipine Besylate Other prescribers in Atlanta, GA | 83 |
| Furosemide Other prescribers in Atlanta, GA | 62 |
| Losartan Potassium Other prescribers in Atlanta, GA | 56 |
| Farxiga (dapagliflozin propanediol) Other prescribers in Atlanta, GA | 50 |
| Torsemide Other prescribers in Atlanta, GA | 41 |
| Carvedilol Other prescribers in Atlanta, GA | 40 |
| Hydralazine Hcl Other prescribers in Atlanta, GA | 36 |
| Jardiance (empagliflozin) Other prescribers in Atlanta, GA | 35 |
| Chlorthalidone Other prescribers in Atlanta, GA | 32 |
| Sevelamer Carbonate Other prescribers in Atlanta, GA | 28 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 8 companies reported 16 payments worth $374 in total to this clinician.
| Mallinckrodt Hospital Products Inc. | $207 |
|---|---|
| Scpharmaceuticals Inc. | $51.33 |
| Novartis Pharmaceuticals Corporation | $32.19 |
| Otsuka America Pharmaceutical, Inc. | $23.96 |
| Bayer HealthCare Pharmaceuticals Inc. | $18.75 |
| Calliditas Therapeutics US Inc. | $18.72 |
| Amgen Inc. | $17.31 |
| Travere Therapeutics, Inc. | $4.41 |
| Food and Beverage | $369 |
|---|---|
| Education | $4.41 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Travere Therapeutics, Inc. Mar 10, 2025 | Education Thiola · Kidney Stones · in-kind | $2.49 |
| Travere Therapeutics, Inc. Mar 10, 2025 | Education Thiola · Kidney Stones · in-kind | $1.92 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.